Lv5
930 积分 2021-10-18 加入
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions
12小时前
已完结
The 2023 ACR/EULAR antiphospholipid syndrome classification criteria
1天前
已完结
Thrombocytopenia in antiphospholipid syndrome: Is anticoagulation and/or antiaggregation always required?
3天前
已完结
ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice
3天前
已完结
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
3个月前
已完结
Clonal dominance: mutations in VEXAS syndrome take advantage of inflammation
3个月前
已完结
Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
3个月前
已完结
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
3个月前
已完结
Clinical Heterogeneity of the VEXAS Syndrome: A Case Series
3个月前
已关闭
Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients
3个月前
已完结
皖公网安备34019202002308
